Search This Blog

Thursday, July 30, 2020

Eli Lilly EPS beats by $0.29, misses on revenue

Eli Lilly (NYSE:LLY): Q2 Non-GAAP EPS of $1.89 beats by $0.29; GAAP EPS of $1.55 beats by $0.02.
Revenue of $5.5B (-2.5% Y/Y) misses by $270M.
Trulicity revenue of $1.23B in-line with consensus.
Humalog sales of $555.1M vs. estimate of $610.5M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)